An FDA official said the agency would have no immediate comment .
The next day surprised FDA officials learned the drug would be pulled .
Five years ago , FitzGerald published research `` revealing a mechanism '' in both Vioxx and Celebrex that could `` predispose people .
Grassley 's committee is one of three in Congress also scrutinizing the FDA 's actions .
I could n't see Merck saying we 're going to market a drug with a safety problem . ''
In addition , in 2003 and earlier this year , they found that more people in the Vioxx group were having cardiovascular events than in the placebo group .
